Prognosis
CDC Panel Talk Ends Without Vote; Pfizer Boost: Virus Update
This article is for subscribers only.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote. Pfizer Inc. and BioNTech SE expect to deliver more vaccines to the European Union this quarter than currently targeted.
Denmark became the first EU country to drop AstraZeneca Plc’s vaccine from its pandemic inoculation program, reflecting the same concerns over blood clots that prompted the J&J pause. Russia said there have been no cases of clotting with its Sputnik vaccine.